Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis
暂无分享,去创建一个
H. Farkas | V. Nădăşan | L. Varga | N. Bara
[1] H. Farkas,et al. A follow‐up survey of patients with acquired angioedema due to C1‐inhibitor deficiency , 2020, Journal of internal medicine.
[2] K. Bork,et al. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate , 2019, Orphanet Journal of Rare Diseases.
[3] M. Cicardi,et al. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. , 2017, The journal of allergy and clinical immunology. In practice.
[4] A. Banerji,et al. Acquired C1 Inhibitor Deficiency. , 2017, Immunology and allergy clinics of North America.
[5] M. Wu,et al. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity , 2016, Clinical chemistry and laboratory medicine.
[6] K. van Besien,et al. Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature , 2012, Leukemia & lymphoma.
[7] H. Iwasaki,et al. Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma , 2005, Annals of Hematology.
[8] A. Gajra,et al. Response of myasthenia gravis to rituximab in a patient with non‐Hodgkin lymphoma , 2004, American journal of hematology.
[9] J. Piette,et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. , 2002, The American journal of medicine.
[10] B. Zweiman,et al. Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. , 1976, Blood.